メインコンテンツに移動
Narrowing scope

Relief (and some regret) as EU scales back swaps transparency

Leaked document outlines plans to narrow scope of dysfunctional OTC disclosure regime

The European Union’s transparency rules for over-the-counter derivatives are widely seen as a failure, with endless problems blighting a regime that was meant to cast a new light on a notoriously opaque and complex market.

Quentin van Lidth, director of regulatory and public affairs at BNP Paribas, sums up the industry’s feeling in a single sentence: “Today, we’ve got post-trade transparency with

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here